Clinical Trial Update: A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer [NA]

View source ↗

Summary

Phase II prospective study evaluating MRI reclassification for men considering active surveillance in prostate cancer; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer | NA | Status: COMPLETED | Results posted: 2022-05-18